Stage IVA Squamous Cell Carcinoma of the Oropharynx Active Not Recruiting Phase 2 / 3 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0029848 (Stage IVA Squamous Cell Carcinoma of the Oropharynx)Active Not Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01810913Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck CancerTreatment